Motherson Sumi shares rose 4% after unveiling five-year roadmap to quadruple revenue to $108 billion by FY2030, double RoCE to 40%, and unlock value via new listings. JPMorgan, Jefferies, and InCred offered mixed optimism on execution. The stock is in recovery mode, finding support at 14-day EMA with RSI at 59. Q2 FY26 results in November are next key trigger.